An Engineered Sirpα Fused to Anti-Pd-L1 And Tgf-β Fusion Protein (HCB301) in Subjects With Selected Advanced Tumors

Name: An Engineered Sirpα Fused to Anti-Pd-L1 And Tgf-β Fusion Protein (HCB301) in Subjects With Selected Advanced Tumors
License: Public Domain

FBD Biologics Limited

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

advanced solid tumor, refractory hodgkin lymphoma

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 623523
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.